4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-17-001522
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 125,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2017-09-19 | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | D | ||
Loading xslF345X03/form4-09202017_010944.xml…